Across TCGA pan-cancer cohorts, RNA5SP374 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNA5SP374 data layer.
The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNA5SP374 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP374 expression acts as an unfavorable survival marker.
OV, BLCA, and TGCT are the cancer types where RNA5SP374 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.